checkAd

     128  0 Kommentare USA Equities Corp. (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine - Seite 2

    About USA Equities Corp (OTCQB: USAQ)

    USA Equities Corp. (USAQ), through its wholly owned subsidiary Medical Practice Income (MPI) a Florida corporation, is focused on value-based healthcare solutions in the digital medicine market, informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, virtual care and preventive medicine. The Company's intellectual properties, products and information service portfolio is directed towards prevention, early detection, management, and reversal of cardiometabolic and other chronic diseases. Our principle objectives are to develop proprietary software tools, devices, and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today's now younger, obese, diabetic and cardiovascular disease population. For more information, visit www.MedicalPracticeIncome.com/discover.

    Forward-Looking Statements

    This press release contains forward-looking statements identified by words such as ‘may’, ‘could’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’, or ‘intends’ and other similar words that involve risks and uncertainties. These statements have not been based solely on historical facts but on USA Equities Corp’s current expectations about future events and results. You should consider that as such statements relate to future matters, they are subject to various inherent risks, uncertainties, and assumptions that could cause actual results or events to differ materially from expectations described in the forward-looking statement. Various important factors could cause actual results or events to differ materially from the forward-looking statements that USA Equities Corp makes, including, but not limited to, the risk that software development and studies may be delayed and may not have satisfactory outcomes, the risk that costs required to continue our Software as a Service (SaaS) or to expand our operations will be higher than anticipated and other risks described in the “Risk Factors” section of our Annual Report on Form 10-K filed by USA Equities Corp with the SEC on February 21, 2020. Except where required by law, USA Equities Corp. has no intention to update or revise forward-looking statements or to publish prospective financial information in the future, regardless of whether new information, future events, or any other factors affect the information contained in this presentation. None of USA Equities Corp Directors, Consultants, or any other person named with their consent in this presentation can assure you that any forward-looking statement or result expressed or implied by any forward-looking statement will be achieved.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    USA Equities Corp. (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine - Seite 2 West Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) - While the recent and rapid development of Pfizer/BioNTech's COVID-19 vaccine is undoubtedly good news, Time Magazine reported that administering this vaccine to individuals with a history of …